429 research outputs found
Heavy quarkonium 2S states in light-front quark model
We study the charmonium 2S states and , and the bottomonium
2S states and , using the light-front quark model and the
2S state wave function of harmonic oscillator as the approximation of the 2S
quarkonium wave function. The decay constants, transition form factors and
masses of these mesons are calculated and compared with experimental data.
Predictions of quantities such as Br are made. The
2S wave function may help us learn more about the structure of these heavy
quarkonia.Comment: 5 latex pages, final version for journal publicatio
Heavy quarkonium: progress, puzzles, and opportunities
A golden age for heavy quarkonium physics dawned a decade ago, initiated by
the confluence of exciting advances in quantum chromodynamics (QCD) and an
explosion of related experimental activity. The early years of this period were
chronicled in the Quarkonium Working Group (QWG) CERN Yellow Report (YR) in
2004, which presented a comprehensive review of the status of the field at that
time and provided specific recommendations for further progress. However, the
broad spectrum of subsequent breakthroughs, surprises, and continuing puzzles
could only be partially anticipated. Since the release of the YR, the BESII
program concluded only to give birth to BESIII; the -factories and CLEO-c
flourished; quarkonium production and polarization measurements at HERA and the
Tevatron matured; and heavy-ion collisions at RHIC have opened a window on the
deconfinement regime. All these experiments leave legacies of quality,
precision, and unsolved mysteries for quarkonium physics, and therefore beg for
continuing investigations. The plethora of newly-found quarkonium-like states
unleashed a flood of theoretical investigations into new forms of matter such
as quark-gluon hybrids, mesonic molecules, and tetraquarks. Measurements of the
spectroscopy, decays, production, and in-medium behavior of c\bar{c}, b\bar{b},
and b\bar{c} bound states have been shown to validate some theoretical
approaches to QCD and highlight lack of quantitative success for others. The
intriguing details of quarkonium suppression in heavy-ion collisions that have
emerged from RHIC have elevated the importance of separating hot- and
cold-nuclear-matter effects in quark-gluon plasma studies. This review
systematically addresses all these matters and concludes by prioritizing
directions for ongoing and future efforts.Comment: 182 pages, 112 figures. Editors: N. Brambilla, S. Eidelman, B. K.
Heltsley, R. Vogt. Section Coordinators: G. T. Bodwin, E. Eichten, A. D.
Frawley, A. B. Meyer, R. E. Mitchell, V. Papadimitriou, P. Petreczky, A. A.
Petrov, P. Robbe, A. Vair
Ant species distribution along a topographic gradient in a "terra-firme" forest reserve in Central Amazonia
Incretin-based therapy: a powerful and promising weapon in the treatment of type 2 diabetes mellitus
Type 2 diabetes mellitus (T2DM) is a progressive multisystemic disease that increases significantly cardiovascular morbidity and mortality. It is associated with obesity, insulin resistance, beta-cell dysfunction, and hyperglucagonemia, the combination of which typically leads to hyperglycemia. Incretin-based treatment modalities, and in particular glucagon-like peptide 1 (GLP-1) receptor agonists, are able to successfully counteract several of the underlying pathophysiological abnormalities of T2DM. The pancreatic effects of GLP-1 receptor agonists include glucose-lowering effects by stimulating insulin secretion and inhibiting glucagon release in a strictly glucose-dependent manner, increased beta-cell proliferation, and decreased beta-cell apoptosis. GLP-1 receptors are widely expressed throughout human body; thus, GLP-1-based therapies exert pleiotropic and multisystemic effects that extend far beyond pancreatic islets. A large body of experimental and clinical data have suggested a considerable protective role of GLP-1 analogs in the cardiovascular system (decreased blood pressure, improved endothelial and myocardial function, functional recovery of failing and ischemic heart, arterial vasodilatation), kidneys (increased diuresis and natriuresis), gastrointestinal tract (delayed gastric emptying, reduced gastric acid secretion), and central nervous system (appetite suppression, neuroprotective properties). The pharmacologic use of GLP-1 receptor agonists has been shown to reduce bodyweight and systolic blood pressure, and significantly improve glycemic control and lipid profile. Interestingly, weight reduction induced by GLP-1 analogs reflects mainly loss of abdominal visceral fat. The critical issue of whether the emerging positive cardiometabolic effects of GLP-1 analogs can be translated into better clinical outcomes for diabetic patients in terms of long-term hard endpoints, such as cardiovascular morbidity and mortality, remains to be elucidated with prospective, large-scale clinical trials
Lactato sanguíneo na avaliação dos efeitos da peridural torácica em cães anestesiados pelo isoflurano
Causas de variação de características de crescimento de bovinos cruzados Canchim x Nelore
Aversão alimentar condicionada para o controle da intoxicação por Ipomoea carnea subsp. fistulosa em caprinos
Gamma-induced background in the KATRIN main spectrometer
International audienceThe KArlsruhe TRItium Neutrino (KATRIN) experiment aims to make a model-independent determination of the effective electron antineutrino mass with a sensitivity of 0.2 eV/c 2 . It investigates the kinematics of β -particles from tritium β -decay close to the endpoint of the energy spectrum. Because the KATRIN main spectrometer (MS) is located above ground, muon-induced backgrounds are of particular concern. Coincidence measurements with the MS and a scintillator-based muon detector system confirmed the model of secondary electron production by cosmic-ray muons inside the MS. Correlation measurements with the same setup showed that about 12% of secondary electrons emitted from the inner surface are induced by cosmic-ray muons, with approximately one secondary electron produced for every 17 muon crossings. However, the magnetic and electrostatic shielding of the MS is able to efficiently suppress these electrons, and we find that muons are responsible for less than 17% (90% confidence level) of the overall MS background
- …